History of Neonatal Screening of Congenital Hypothyroidism in Portugal

Abstract

by Maria José Costeira,Patrício Costa,Susana Roque,Ivone Carvalho,Laura Vilarinho andJoana Almeida Palha
Int. J. Neonatal Screen. 2024, 10(1), 16; https://doi.org/10.3390/ijns10010016 - 20 AUG 2024
Cited by 2 | Viewed by 1663
Abstract
Congenital hypothyroidism (CH) leads to growth and development delays and is preventable with early treatment. Neonatal screening for CH was initiated in Portugal in 1981. This study examines the history of CH screening in the country. Data were obtained from annual reports and from the national database of neonatal screening laboratory. The CH screening strategy primarily relies on the thyroid-stimulating hormone (TSH), followed by total thyroxine measurement as the second tier for confirmation. The TSH cutoff started at 90 mIU/L, decreasing to the actual 10 mIU/L. The coverage of the screening program has increased rapidly; although voluntary, it reached about 90% in 6 years and became universal in 10 years. Guideline and cutoff updates led to the identification of over 200 additional cases, resulting in specific retesting protocols for preterm and very-low-birth-weight babies. The actual decision tree considers CH when TSH levels are above 40 mIU/L. Data from the CH screening also provide an indication of the iodine status of the population, which is presently indicative of iodine insufficiency. The Portuguese neonatal screening for CH is a history of success. It has rapidly and continuously adapted to changes in knowledge and has become a universal voluntary practice within a few years. Full article
(This article belongs to the Special Issue Neonatal Screening in Europe: On the Brink of a New Era)
► Show Figures
12 pages, 1462 KiB
Open AccessArticle